Skip to content
★ Sign in to follow
Total declarations
14
Company
1
▲ Purchases (1 ops.)
—
▼ Sales (11 ops.)
—

Latest filing published 31 Aug 2026 for 에스바이오메딕스.

Insider track record

Disclosed buys
1
Disclosed sells
11

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

No signal scores available.

Kang Saeil: trading record in brief

Kang Saeil discloses dealings in 에스바이오메딕스 to DART (FSS). Over a trading history stretching from 4 May 2023 to 31 August 2026, the count stands at 14 filings.

Both buying and selling appear: 1 purchase, against 11 sales. No amount is published for 12 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2026 to date brings no purchases and 2 sales.

The newest entry dates from 31 August 2026: an open-market sale, in 에스바이오메딕스. The last purchase on record was published on 14 June 2024, which is 878 days ago. Between a trade and the moment it shows up on DART (FSS), the median delay is 6 days. Until a filing is published, the market cannot know about the trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from DART (FSS). Past trades are no guide to future returns.

Companies and markets linked to Kang Saeil

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations14 total

14 of 14 declarations